参考文献
[1] Zhang W, Xia W, Lv Z, Xin Y, Ni C, Yang L. Liquid biopsy for cancer: circulating tumor cells, circulating free dna or exosomes? CPB. 2017;41(2):755-768. doi:10.1159/000458736
[2] Mathai R, Vidya R, Reddy B, et al. Potential utility of liquid biopsy as a diagnostic and prognostic tool for the assessment of solid tumors: implications in the precision oncology. JCM. 2019;8(3):373. doi:10.3390/jcm8030373
[3] Crowley E, Di Nicolantonio F, Loupakis F, Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. 2013;10(8):472-484. doi:10.1038/nrclinonc.2013.110
[4] Qi Z, Xu H, Zhang S et al. The Significance of Liquid Biopsy in Pancreatic Cancer. J Cancer. 2018;9(18):3417-3426. doi:10.7150/jca.24591
[5] Panditharatna E, Kilburn LB, Aboian MS, et al. Clinically relevant and minimally invasive tumor surveillance of pediatric diffuse midline gliomas using patient-derived liquid biopsy. Clin Cancer Res. 2018;24(23):5850-5859. doi:10.1158/1078-0432.CCR-18-1345
[6] Turner NC, Kingston B, Kilburn LS, et al. Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasma MATCH): a multicentre, multicohort, phase 2a, platform trial. The Lancet Oncology. 2020;21(10):1296-1308. doi:10.1016/s1470-2045(20)30444-7
[7] Saarenheimo J, Eigeliene N, Andersen H, Tiirola M, Jekunen A. The value of liquid biopsies for guiding therapy decisions in non-small cell lung cancer. Front Oncol. 2019;9:129. doi:10.3389/fonc.2019.00129
[8] Buscail E, Alix-Panabières C, Quincy P, et al. High clinical value of liquid biopsy to detect circulating tumor cells and tumor exosomes in pancreatic ductal adenocarcinoma patients eligible for up-front surgery. Cancers. 2019;11(11):1656. doi:10.3390/cancers11111656
[9] Cohen JD, Li L, Wang Y, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359(6378):926-930. doi:10.1126/science.aar3247
[10] Lambros MB, Seed G, Sumanasuriya S, et al. Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis. Clinical Cancer Research. 2018;24(22). doi:10.1158/1078-0432.CCR-18-0862
[11] Lee RJ, Gremel G, Marshall A, et al. Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma. Annals ofOncology. 2018;29(2):490-496. doi:10.1093/annonc/mdx717
[12] Rossi G, Ignatiadis M. Promises and pitfalls of using liquid biopsy for precision medicine. Cancer Res. 2019;79(11):2798-2804. doi:10.1158/0008-5472.CAN-18-3402
Neumann MHD, Bender S, Krahn T, Schlange T. ctDNA and CTCs in Liquid Biopsy – Current Status and Where We Need to Progress. Computational and Structural Biotechnology Journal. 2018;16:190-195. doi:10.1016/j.csbj.2018.05.002
/3 
浙公网安备33010802005999号 
